ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Oral Presentation
Chairs: S. Loukides (Voula, Greece), F. Schleich (Liège, Belgium)

Late Breaking Abstract - Aging change the protein-profile of lining fluid from small airways J. Östling (Mölndal, Sweden)
Hair analysis to detect chronic inhaler drug use in asthma or COPD patients D. Hassall (Middlesex, United Kingdom)
A simple score for future risk prediction in patients with controlled asthma who undergo a step-down guidelines-based strategy. L. Pérez De Llano (Lugo, Spain)
Association between blood eosinophil counts and risk of rehospitalization in patients with asthma M. Kerkhof (NORFOLK, United Kingdom)
Is residual volume reversibility a better marker than FEV1 reversibility in diagnosing reversible airway disease in asthma? J. Vempilly (Fresno, United States of America)
Bronchodilator response and previous lung function decline in relation with exhaled nitric oxide levels in asthma A. Malinovschi (Uppsala, Sweden)
Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma R. Sehmi (Hamilton, ON, Canada)
Cell counts in severe asthma; concordance of sputum and BAL in Wessex Severe Asthma Cohort T. Jones (Portsmouth, United Kingdom)